Heparin-like glycosaminoglycans, acidic complex polysaccharides present on cell surfaces and in the extracellular matrix, regulate important physiological processes such as anticoagulation and angiogenesis. Heparin-like glycosaminoglycan degrading enzymes or heparinases are powerful tools that have enabled the elucidation of important biological properties of heparin-like glycosaminoglycans in vitro and in vivo. With an overall goal of developing an approach to sequence heparin-like glycosaminoglycans using the heparinases, we recently have elaborated a mass spectrometry methodology to elucidate the mechanism of depolymerization of heparin-like glycosaminoglycans by heparinase I. In this study, we investigate the mechanism of depolymerization of heparin-like glycosaminoglycans by heparinase II, which possesses the broadest known substrate specificity of the heparinases. We show here that heparinase II cleaves heparin-like glycosaminoglycans endolytically in a nonrandom manner. In addition, we show that heparinase II has two distinct active sites and provide evidence that one of the active sites is heparinase I-like, cleaving at hexosamine-sulfated iduronate linkages, whereas the other is presumably heparinase III-like, cleaving at hexosamine-glucuronate linkages. Elucidation of the mechanism of depolymerization of heparinlike glycosaminoglycans by the heparinases and mutant heparinases could pave the way to the development of much needed methods to sequence heparin-like glycosaminoglycans.Heparin-like glycosaminoglycans (HLGAGs) are one of the major components of the extracellular matrix and are present at the cell surface as part of proteoglycans (1, 2). HLGAGs are complex polysaccharides characterized by a disaccharide repeat unit of a uronic acid (either L-iduronic acid or Dglucuronic acid) which is linked 1-4 to a glucosamine (3). The modification of the functional groups of the sugar units (i.e., 2-O sulfate on the uronic acid and 3-O, 6-O, and N-sulfation of the hexosamine) (4), taken together with the variation in the chain length make HLGAGs the most acidic and heterogenous biopolymers. Together, these modifications allow for a wide array of HLGAG sequences and present a daunting challenge to understanding how certain sequences of HLGAGs elicit a biological response.Of importance then is the development of molecular tools to study the in vivo roles of HLGAG sequences. One such strategy, being developed in our laboratories, is to use HL-GAG degrading enzymes, or heparinases, to investigate the role and composition of biologically relevant HLGAG sequences. Three heparinases (I, II, and III) have been isolated from Flavobacterium heparinum; they differ from one another in terms of their size, molecular characteristics, and substrate specificities (5). By using these heparinases we have provided evidence for HLGAG involvement in fundamental biological processes such as angiogenesis (6) and development (7). While the heparinases have shown their use in delineating specific biological roles for HLGAG s...